BioMérieux S.A. BioMérieux S.A.

BioMérieux S.A.

BIM

Rankning i aktier #1760
bioMérieux S.A. is a global entity operating across the Americas, Europe, the... bioMérieux S.A. is a global entity operating across the Americas, Europe, the Middle East, Africa, and the Asia Pacific, specializing in the development and production of in vitro diagnostic solutions. The company's sophisticated systems utilize biological samples to identify infectious diseases, cardiovascular conditions, and various forms of cancer. Additionally, bioMérieux provides essential microbiological testing services for the manufacturing sectors, primarily serving the food, pharmaceutical, cosmetics, and veterinary industries. Its client base includes clinical and hospital laboratories, medical practitioners, blood banks, and industrial quality control facilities. Founded in 1963, originally under the name B-D Mérieux, bioMérieux S.A. maintains its headquarters in Marcy l'Etoile, France, and functions as a subsidiary of Institut Mérieux SA.
Aktiekurs
$103.91
Marknadsvärde
$12.23B
Förändring (1 dag)
0.86%
Förändring (1 år)
-19.74%
Land
FR
Handel BioMérieux S.A. (BIM)

Kategori

Healthcare
Utdelningsavkastning för BioMérieux S.A. (BIM)
Utdelningsavkastningen (TTM) för BioMérieux S.A. (aktiesymbol: BIM) per 2023-12-31 är: 0.84%
Genomsnittlig utdelningsavkastning de senaste 5 åren: 0.64%
Historik för utdelningsavkastning för BioMérieux S.A. (BIM) från 2005 till 2026
Utdelningsavkastning i slutet av varje år (TTM)
År Utdelningsavkastning Ändra
2026 (TTM) 1.14% 39.02%
2024 0.82% -2.38%
2023 0.84% -4.55%
2022 0.88% 79.59%
2021 0.49% 188.24%
2020 0.17% -61.36%
2019 0.44% -25.42%
2018 0.59% 31.11%
2017 0.45% -36.62%
2016 0.71% -21.98%
2015 0.91% -22.22%
2014 1.17% -8.59%
2013 1.28% -5.88%
2012 1.36% -23.60%
2011 1.78% 42.40%
2010 1.25% 26.26%
2009 0.99% -21.43%
2008 1.26% 31.25%
2007 0.96% 7.87%
2006 0.89% -1.11%
2005 0.90% 0.00%
Utdelningsavkastning (TTM) för liknande företag eller konkurrenter